Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic LeukemiaAndy C. Rawstron, Peter Hillmen, Ruth de Tute et al.|New England Journal of Medicine|2008Cited by 605
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual DiseaseTalha Munir, Peter Hillmen, David A. Cairns et al.|New England Journal of Medicine|2023Cited by 155
Acquired Bruton's tyrosine kinase mutations in patients treated on the ibrutinib and rituximab, ibrutinib alone, and ibrutinib and venetoclax arms of the national multi-centre Phase III FLAIR study in previously untreated CLL patientsCharlotte Evans, Talha Munir, Surita Dalal et al.|Blood|2025Cited by 2